German Isentress Case Could Mean More Compulsory Licensing In Europe
A German court’s decision to uphold a compulsory license allowing Merck & Co to keep on selling its HIV drug Isentress could pave the way for more compulsory licensing in Europe.
A German court’s decision to uphold a compulsory license allowing Merck & Co to keep on selling its HIV drug Isentress could pave the way for more compulsory licensing in Europe.